KOINOBORI Associate Inc has focused on mitochondrial diseases and has worked to establish a specific, effective treatment. 7SP is a drug development project to develop new treatments and provide knowledge for the public in order to improve the quality of
The origin of 7 SEAS (“Nanami” in Japanese) comes from the name given wholeheartedly to the beloved daughter of one of our members who loves the sea. Nanami was diagnosed with a mitochondrial disease called Leigh’s encephalomyelopathy at five months of age, and although her doctor declared that she had only six months to live, she is still living with her parents at the age of six.
To realize 7SP, we hereby establish 7SP Research Network to promote the social drug development business by creating a research network between venture companies and the departments of medicine, pharmaceuticals, agriculture, and engineering of six Japanese universities. For details, refer to 7 SEAS PROJECT Web site. (www.7seasproject.net)
KOINOBORI conducts active support of 7 SEAS PROJECT, such as fundraising, research and development, and business development, and it supports the expeditious provision of innovative treatment.